1. Management of Intra-Abdominal Infections: The Role of Procalcitonin.
- Author
-
Tian, Brian W. C. A., Agnoletti, Vanni, Ansaloni, Luca, Coccolini, Federico, Bravi, Francesca, Sartelli, Massimo, Vallicelli, Carlo, and Catena, Fausto
- Subjects
INTRA-abdominal infections ,CALCITONIN ,NOSOCOMIAL infections ,LITERATURE reviews ,C-reactive protein - Abstract
Patients with intra-abdominal sepsis suffer from significant mortality and morbidity. The main pillars of treatment for intra-abdominal infections are (1) source control and (2) early delivery of antibiotics. Antibiotic therapy should be started as soon as possible. However, the duration of antibiotics remains a matter of debate. Prolonged antibiotic delivery can lead to increased microbial resistance and the development of nosocomial infections. There has been much research on biomarkers and their ability to aid the decision on when to stop antibiotics. Some of these biomarkers include interleukins, C-reactive protein (CRP) and procalcitonin (PCT). PCT's value as a biomarker has been a focus area of research in recent years. Most studies use either a cut-off value of 0.50 ng/mL or an >80% reduction in PCT levels to determine when to stop antibiotics. This paper performs a literature review and provides a synthesized up-to-date global overview on the value of PCT in managing intra-abdominal infections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF